For informational purposes only — not investment advice

← Back to signals

MYGN

MYRIAD GENETICS INC

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
2.0d↓-1.3%
as of 2026-10-30 · shares short vs 2026-09-30

Fund 13D/13G Filings (2)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Glenview CapitalSC 13G/A—0.0%
+89.7% vs SPY
+87.5% abs
2026-08-14↗
Glenview CapitalSC 13GNEW5.3%—2026-01-13↗

Tracked Funds Holding (1)

FundManagerShares HeldPosition Value
Point72Steve Cohen3.2M$14M

Quarter-end 13F positions for the tracked funds holding this stock.